Susquehanna International Group
RYTM icon

Susquehanna International Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Susquehanna International Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.21M Sell
82,900
-129,900
-61% -$12.6M ﹤0.01% 3606
2025
Q4 		$22.8M Sell
212,800
-46,800
-18% -$4.96M ﹤0.01% 2068
2025
Q3 		$26.2M Buy
259,600
+199,400
+331% +$18.5M ﹤0.01% 1918
2025
Q2 		$3.8M Sell
60,200
-28,600
-32% -$1.75M ﹤0.01% 4496
2025
Q1 		$4.7M Sell
88,800
-26,500
-23% -$1.47M ﹤0.01% 3769
2024
Q4 		$6.45M Sell
115,300
-117,300
-50% -$6.48M ﹤0.01% 3223
2024
Q3 		$12.2M Buy
232,600
+139,100
+149% +$6.67M ﹤0.01% 2363
2024
Q2 		$3.84M Sell
93,500
-169,200
-64% -$6.75M ﹤0.01% 3879
2024
Q1 		$11.4M Sell
262,700
-8,300
-3% -$363K ﹤0.01% 2433
2023
Q4 		$12.5M Buy
271,000
+219,600
+427% +$6.93M ﹤0.01% 2355
2023
Q3 		$1.18M Buy
51,400
+16,600
+48% +$372K ﹤0.01% 6268
2023
Q2 		$574K Sell
34,800
-70,300
-67% -$1.27M ﹤0.01% 7985
2023
Q1 		$1.87M Buy
105,100
+29,600
+39% +$743K ﹤0.01% 5276
2022
Q4 		$2.2M Sell
75,500
-202,700
-73% -$5.21M ﹤0.01% 4523
2022
Q3 		$6.82M Buy
278,200
+168,500
+154% +$3.13M ﹤0.01% 2693
2022
Q2 		$455K Buy
109,700
+5,200
+5% +$28.5K ﹤0.01% 8514
2022
Q1 		$1.2M Buy
+104,500
New +$917K ﹤0.01% 6645
2021
Q1 		– Sell
-56,500
Closed -$1.68M – 12773
2020
Q4 		$1.68M Buy
56,500
+46,800
+482% +$1.19M ﹤0.01% 5482
2020
Q3 		$210K Buy
+9,700
New +$222K ﹤0.01% 9370
2019
Q4 		– Sell
-9,900
Closed -$214K – 10495
2019
Q3 		$214K Buy
+9,900
New +$212K ﹤0.01% 8970

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Susquehanna International Group's RYTM Position: Q1 2026 in Review

Susquehanna International Group increased its Rhythm Pharmaceuticals (RYTM) stake by 1,140% in Q1 2026, buying an estimated $4.54M and bringing the position to 50,784 shares worth $4.42M. The position accounts for ﹤0.01% of the portfolio, ranked #4463.

Susquehanna International Group first reported a position in RYTM in Q2 2019 and has held it in 27 quarters since. The position peaked at $20.2M in Q4 2022. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Susquehanna International Group held 50,784 shares of Rhythm Pharmaceuticals worth $4.42M as of Q1 2026.
  • Susquehanna International Group bought 46,687 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $4.54M.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4463 holding.
  • Susquehanna International Group first reported a position in Rhythm Pharmaceuticals in Q2 2019 and has held it in 27 quarters since.
  • Susquehanna International Group's Rhythm Pharmaceuticals position peaked at $20.2M in Q4 2022.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.